Monte Rosa Therapeutics (GLUE) Other Gross PP&E Adjustments: 2023-2025
Historic Other Gross PP&E Adjustments for Monte Rosa Therapeutics (GLUE) over the last 3 years, with Sep 2025 value amounting to $28.1 million.
- Monte Rosa Therapeutics' Other Gross PP&E Adjustments rose 25.36% to $28.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $102.3 million, marking a year-over-year increase of 26.35%. This contributed to the annual value of $23.0 million for FY2024, which is 33.51% up from last year.
- According to the latest figures from Q3 2025, Monte Rosa Therapeutics' Other Gross PP&E Adjustments is $28.1 million, which was up 4.66% from $26.8 million recorded in Q2 2025.
- Monte Rosa Therapeutics' Other Gross PP&E Adjustments' 5-year high stood at $28.1 million during Q3 2025, with a 5-year trough of $13.5 million in Q2 2023.
- Over the past 3 years, Monte Rosa Therapeutics' median Other Gross PP&E Adjustments value was $21.6 million (recorded in 2024), while the average stood at $20.7 million.
- Data for Monte Rosa Therapeutics' Other Gross PP&E Adjustments shows a peak YoY skyrocketed of 59.21% (in 2024) over the last 5 years.
- Quarterly analysis of 3 years shows Monte Rosa Therapeutics' Other Gross PP&E Adjustments stood at $17.2 million in 2023, then soared by 33.51% to $23.0 million in 2024, then grew by 25.36% to $28.1 million in 2025.
- Its last three reported values are $28.1 million in Q3 2025, $26.8 million for Q2 2025, and $24.4 million during Q1 2025.